Quick Dispatch:
Your tirzepatide for psoriatic arthritis Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide for psoriatic arthritis Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity ships.
Need Help?
Questions about tirzepatide for psoriatic arthritis Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide for psoriatic arthritis Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity in your area.
People living with psoriatic arthritis are more likely to also have obesity. New clinical trial results showed an integrated treatment approach with two approved Lilly medicines significantly improved psoriatic arthritis activity and
24.58
GLP-1 Agonists and Psoriasis: A Potential Novel Therapeutic Approach
23.60
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial - Merola
22.06
Full Data on TOGETHER-PsA
26.06
Tirzepatide Psoriasis
25.02
Ixekizumab With Tirzepatide Efficacy in Obese Psoriatic Arthritis
22.09
Results of the phase 3b TOGETHER-PsA trial showed ixekizumab administered together with tirzepatide in comorbid overweight or obese adults with psoriatic arthritis showed clinically meaningful improvement of psoriatic disease, physical function, weight
21.54
